Catalyst Wire Dossier Catalyst Wire Dossier

Opti-Free III

· Alcon Research
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Opti-Free III, covering 2015-06-10 to 2015-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan [NA]

See pricing